Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
石川 諒尚; 田中 浩基*; 中村 哲志*; 熊田 博明*; 櫻井 良憲*; 渡辺 賢一*; 吉橋 幸子*; 棚上 裕生*; 瓜谷 章*; 鬼柳 善明*
Journal of Radiation Research (Internet), 11 Pages, 2024/10
被引用回数:0From the viewpoints of the advantage depths (ADs), peak tumor dose, and skin dose, we evaluated the effect of neutron beam properties, namely, the ratio between thermal and epithermal neutron fluxes (thermal/epithermal ratio), fast neutron component, and -ray component on the dose distribution. Several parameter surveys were conducted with respect to the beam properties of neutron sources for boron neutron capture therapy assuming boronophenylalanine as the boron agent using our dose calculation tool, called SiDE. The ADs decreased by 3% at a thermal/epithermal ratio of 20% - 30% compared with the current recommendation of . The skin dose increased with the increasing thermal/epithermal ratio, reaching a restricted value of 14 Gy-eq at a thermal/epithermal ratio of . The fast neutron component was modified using two different models, namely, the "linear model," in which the fast neutron intensity decreases log-linearly with the increasing neutron energy, and the "moderator thickness (MT) model," in which the fast neutron component is varied by adjusting the moderator thickness in a virtual beam shaping assembly. Although a higher fast neutron component indicated a higher skin dose, the increment was at a fast neutron component of Gy cm for both models. Furthermore, in the MT model, the epithermal neutron intensity was higher at a fast neutron component of Gy cm compared with the current recommendation of Gy cm. The -ray component also caused no significant disadvantages up to several times larger compared with the current recommendation.